NDC product
RUMEX CRISPUS POLLEN
NDC 0268-6622 · ALK-Abello, Inc.
Key facts
| Product NDC | 0268-6622 |
|---|---|
| Proprietary name | RUMEX CRISPUS POLLEN |
| Nonproprietary name | Yellow Dock |
| Substances | RUMEX CRISPUS POLLEN |
| Dosage form | INJECTION, SOLUTION |
| Route | PERCUTANEOUS |
| Labeler | ALK-Abello, Inc. |
| Product type | NON-STANDARDIZED ALLERGENIC |
| Marketing category | BLA |
| Application number | BLA103753 |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS] |
| Marketing start | Jan 1, 1965 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: